There were 253 press releases posted in the last 24 hours and 431,460 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Ascendis Pharma A/S Receives Orphan Drug Designation for TransCon™ hGH as Treatment for Growth Hormone Deficiency in the United States

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image